Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2007 7
2008 10
2009 4
2010 10
2011 6
2012 6
2013 8
2017 1
2018 3
2019 4
2020 4
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Results by year
Filters applied: . Clear all
Page 1
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial.
Brigham EP, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Diserens JE, Martinez FJ, McCormack MC, Newby DE, Yates J, Vestbo J, Wu TD, Wise RA. Brigham EP, et al. Among authors: cowans nj. ERJ Open Res. 2021 Jul 26;7(3):00902-2020. doi: 10.1183/23120541.00902-2020. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34322545 Free PMC article.
Cigarette smoking and response to inhaled corticosteroids in COPD.
Bhatt SP, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Newby DE, Vestbo J, Yates JC, Dransfield MT. Bhatt SP, et al. Among authors: cowans nj. Eur Respir J. 2018 Jan 18;51(1):1701393. doi: 10.1183/13993003.01393-2017. Print 2018 Jan. Eur Respir J. 2018. PMID: 29348179 Free article. Clinical Trial. No abstract available.
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT.
Vestbo J, Dransfield M, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez F, Newby DE, Yates J, Lange P. Vestbo J, et al. Among authors: cowans nj. ERJ Open Res. 2019 Feb 25;5(1):00203-2018. doi: 10.1183/23120541.00203-2018. eCollection 2019 Feb. ERJ Open Res. 2019. PMID: 30815468 Free PMC article.
Regional differences in rate of FEV1 decline in COPD: lessons from SUMMIT.
Celli BR, Anderson JA, Brook RD, Calverley PMA, Cowans NJ, Crim C, Martinez F, Newby DE, Yates J, Vestbo J. Celli BR, et al. Among authors: cowans nj. Eur Respir J. 2019 Jun 27;53(6):1900278. doi: 10.1183/13993003.00278-2019. Print 2019 Jun. Eur Respir J. 2019. PMID: 30923182 Free article. Clinical Trial. No abstract available.
Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial.
Crim C, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Brook RD. Crim C, et al. Among authors: cowans nj. Am J Respir Crit Care Med. 2020 May 15;201(10):1307-1310. doi: 10.1164/rccm.201908-1639LE. Am J Respir Crit Care Med. 2020. PMID: 32017597 Clinical Trial. No abstract available.
FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease.
Bikov A, Lange P, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Yates JC, Vestbo J. Bikov A, et al. Among authors: cowans nj. Int J Chron Obstruct Pulmon Dis. 2020 May 20;15:1135-1142. doi: 10.2147/COPD.S242809. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32547001 Free PMC article.
67 results